GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (XAMS:PHARM) » Definitions » Short Interest

Pharming Group (XAMS:PHARM) Short Interest


View and export this data going back to 1998. Start your Free Trial

What is Pharming Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Pharming Group's Short Interest

For the Biotechnology subindustry, Pharming Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Pharming Group's Short Interest falls into.



Pharming Group (XAMS:PHARM) Business Description

Traded in Other Exchanges
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group (XAMS:PHARM) Headlines

No Headlines